ARM’s (ARM) Overweight Rating Reaffirmed at Barclays

Barclays restated their overweight rating on shares of ARM (NASDAQ:ARM) in a report released on Thursday,Benzinga reports. They currently have a $165.00 price objective on the stock.

Other analysts have also issued research reports about the company. UBS Group lowered their target price on ARM from $175.00 to $170.00 and set a “buy” rating on the stock in a report on Thursday, February 5th. Citigroup lowered ARM from a “buy” rating to a “hold” rating in a report on Tuesday, January 13th. Susquehanna raised ARM from a “neutral” rating to a “positive” rating and set a $150.00 price objective for the company in a research report on Wednesday, January 21st. The Goldman Sachs Group downgraded shares of ARM from a “neutral” rating to a “sell” rating and lowered their price objective for the stock from $160.00 to $120.00 in a research note on Monday, December 15th. Finally, Bank of America reaffirmed a “neutral” rating and set a $120.00 target price on shares of ARM in a research report on Tuesday, January 13th. Nineteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, ARM presently has an average rating of “Moderate Buy” and an average price target of $168.17.

ARM Trading Down 1.4%

NASDAQ:ARM opened at $154.80 on Thursday. The firm has a market capitalization of $163.55 billion, a PE ratio of 206.40, a PEG ratio of 10.84 and a beta of 4.11. ARM has a 1 year low of $80.00 and a 1 year high of $183.16. The firm’s fifty day simple moving average is $121.71 and its 200 day simple moving average is $134.31.

ARM (NASDAQ:ARM) last released its earnings results on Wednesday, February 4th. The company reported $0.43 earnings per share for the quarter, topping analysts’ consensus estimates of $0.41 by $0.02. The firm had revenue of $1.24 billion during the quarter, compared to analyst estimates of $1.23 billion. ARM had a net margin of 17.15% and a return on equity of 14.01%. The business’s revenue was up 26.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.39 EPS. ARM has set its Q4 2026 guidance at 0.540-0.620 EPS. As a group, analysts anticipate that ARM will post 0.9 EPS for the current fiscal year.

Institutional Trading of ARM

A number of hedge funds have recently modified their holdings of the company. GAMMA Investing LLC increased its position in shares of ARM by 126.0% during the third quarter. GAMMA Investing LLC now owns 174 shares of the company’s stock valued at $25,000 after purchasing an additional 97 shares during the period. Grey Fox Wealth Advisors LLC acquired a new position in shares of ARM in the third quarter valued at $28,000. FWL Investment Management LLC bought a new position in ARM in the second quarter worth $34,000. Mcguire Capital Advisors Inc. acquired a new stake in ARM during the fourth quarter worth $30,000. Finally, Strategic Investment Solutions Inc. IL boosted its stake in ARM by 238.1% during the third quarter. Strategic Investment Solutions Inc. IL now owns 284 shares of the company’s stock worth $40,000 after buying an additional 200 shares in the last quarter. Institutional investors own 7.53% of the company’s stock.

More ARM News

Here are the key news stories impacting ARM this week:

• Positive Sentiment: Arm unveiled the AGI CPU (first-ever in-house chip) and gave long-range revenue guidance that repositions the company from licensor to direct silicon seller — a transformational growth narrative. Arm’s New Gambit: Building Chips to Challenge the AI Titans
• Positive Sentiment: Meta signed on as the launch/customer partner for the new CPU, which materially de‑risks commercialization and provides an early scale buyer. Arm jumps 13% in premarket after saying first in-house chip set to generate $15 billion in revenue
• Positive Sentiment: Analysts have moved quickly to upgrade and raise targets (Needham upgraded to Buy with a $200 target; multiple firms raised PTs), signaling higher earnings and valuation expectations if execution succeeds. Arm Stock Upgraded After Move from Blueprints to Silicon. A ‘Credible AI Play’ Is Born.
• Neutral Sentiment: Technical/market metrics show momentum—Relative Strength rating jumped—indicating institutional interest, but that can also amplify volatility after a big gap-up. Arm Holdings Stock Sees Relative Strength Rating Jump To 87
• Neutral Sentiment: Unusually large call-option activity accompanied the rally — bullish interest but also a potential source of short-term gamma-driven moves. (Market commentary summarized across reports.)
• Negative Sentiment: Major outlets and strategists warn execution risk: moving from IP licensing to manufacturing/sales is complex and the stock’s high valuation already prices in substantial success; failure or delays would pressure shares. Arm’s Timing Is Good, but Big Chip Move Now Has to Go Perfectly
• Negative Sentiment: After Wednesday’s surge (big one‑day gains), profit-taking and overbought indicators triggered a pullback today — typical after a rapid re‑rating. Arm jumps as new AI chip to drive billions annual revenue

About ARM

Arm Limited (NASDAQ: ARM) is a global semiconductor IP company best known for designing energy-efficient processor architectures and related technologies that underpin a wide range of computing devices. Founded in 1990 as a joint venture between Acorn Computers, Apple and VLSI Technology and headquartered in Cambridge, England, Arm develops the ARM instruction set architectures and core processor designs that chipmakers license and integrate into custom system-on-chip (SoC) products. The company operates a licensing and royalty business model rather than manufacturing chips itself.

Arm’s product portfolio includes CPU core families (such as Cortex and Neoverse lines), GPU and multimedia IP (Mali), neural processing units (Ethos) and a suite of system and physical IP blocks.